Silent atrial fibrillation: clinical management and perspectives.
Holter
anticoagulant therapy
atrial fibrillation
electrocardiogram
stroke
Journal
Future cardiology
ISSN: 1744-8298
Titre abrégé: Future Cardiol
Pays: England
ID NLM: 101239345
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
pubmed:
4
3
2020
medline:
12
8
2021
entrez:
4
3
2020
Statut:
ppublish
Résumé
Silent atrial fibrillation (AF) is an asymptomatic atrial arrhythmia that can be diagnosed by chance during a systematic electrocardiogram, an external Holter, or from implanted cardiac devices. There is a significant body of the literature around silent AF, yet it remains largely underdiagnosed in everyday clinical practice. Meanwhile, new diagnostic tools have significantly improved the detection of silent AF, creating a potential for mass screening via new technologies and the promise of a major step forward in e-health progress. However, it is not yet known whether silent AF is associated with the same thromboembolic risk as symptomatic AF, and whether these asymptomatic and often short-lasting episodes therefore require anticoagulation therapy and rhythm management.
Identifiants
pubmed: 32125174
doi: 10.2217/fca-2019-0066
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM